Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Jakubowski
    Jakubowski
  4. Devlin
    Devlin
  5. Papadopoulos
    Papadopoulos
  6. Shah
    Shah
  7. Ponce
    Ponce
  8. Castro-Malaspina
    Castro-Malaspina
  9. Scordo
    Scordo
  10. Landau
    Landau

Groups

  1. Bone Marrow Transplant (727)
  2. Center for Hematologic Malignancies (727)
  3. Department of Medicine (727)
  4. Hematologic Malignancies, Division of (701)
  5. Survivorship Research (367)
  6. CTCR Scholars (271)
  7. MSK Grad Students (208)
  8. Epidemiology and Biostatistics (206)
  9. GSK Faculty (205)
  10. Biostatistics Service (204)
Search Within
  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (403)
  2. Journal Article (280)
  3. Review (16)
  4. Guidelines (15)
  5. Editorial (4)
  6. Book Section (3)
  7. Conference Paper (3)
  8. Correspondence (2)
  9. Research Letter (1)
Groups
  1. Bone Marrow Transplant (727)
  2. Center for Hematologic Malignancies (727)
  3. Department of Medicine (727)
  4. Hematologic Malignancies, Division of (701)
  5. Survivorship Research (367)
  6. CTCR Scholars (271)

More Groups

People
  1. Sergio Giralt (368)
  2. Miguel-Angel Perales (289)
  3. Ann Jakubowski (163)
  4. Sean Devlin (160)
  5. Juliet Barker (157)
  6. Esperanza Papadopoulos (137)

More People

Years
  1. 2024 (5)
  2. 2023 (44)
  3. 2022 (57)
  4. 2021 (34)
  5. 2020 (73)
  6. 2019 (81)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (516)
  2. Transplantation and Cellular Therapy (96)
  3. Clinical Lymphoma, Myeloma and Leukemia (64)
  4. Hematology/Oncology Clinics of North America (6)
  5. International Journal of Radiation Oncology, Biology, Physics (6)
  6. Best Practice and Research: Clinical Haematology (3)

More Publications

Results (727)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Donor-derived malignancy and transplantation morbidity: Risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation
    Review

    Williams, L. S.; Williams, K. M.; Gillis, N.; Bolton, K.; Damm, F.; Deuitch, N. T.; Farhadfar, N.; Gergis, U.; Keel, S. B.; Michelis, F. V.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Incidence and impact of fungal infections in post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical hematopoietic cell transplantation: A center for international blood and marrow transplant research analysis
    Journal Article

    Papanicolaou, G. A.; Chen, M.; He, N.; Martens, M. J.; Kim, S.; Batista, M. V.; Bhatt, N. S.; Hematti, P.; Hill, J. A.; Liu, H.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cell therapy for myeloma: Where are we now and what is needed to move chimeric antigen receptor T cells forward to earlier lines of therapy? Expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Guidelines

    Anderson, L. D. Jr; Dhakal, B.; Jain, T.; Oluwole, O. O.; Shah, G. L.; Sidana, S.; Perales, M. A.; Pasquini, M. C.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Patterns of failure in 559 primary central nervous system lymphoma patients treated from 1983-2020
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Grommes, C.; Imber, B.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Consolidation patterns and associated outcomes for a large cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B.; Tringale, K.; Scordo, M.; Yahalom, J.; Grommes, C.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Salvage radiotherapy as a bridge for relapsed secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K. R.; Hajj, C.; Hubbeling, H. G.; Sarkar, R. R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Pike, L. R. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save